Riley Lovendale is an associate in Goodwin’s Technology and Life Sciences Group and a member of the firm’s Strategic Technology Transactions and Licensing practice. Mr. Lovendale represents public and private companies in all stages of maturity in the technology and life sciences industries, both in the United States and internationally. His experience encompasses public offerings, including those involving foreign issuers seeking to access the U.S. capital markets, and venture capital financings; intellectual property and licensing transactions; and due diligence and other intellectual property issues in mergers, acquisitions, and venture capital and private equity transactions. Mr. Lovendale also regularly counsels both U.S. and non-U.S. companies with respect to SEC reporting and securities law compliance, intellectual property issues, corporate governance, and general corporate matters. He joined Goodwin in 2014.





Mr. Lovendale’s representative clients and transactions include:

Public Offerings

  • argenx SE in its $115 million initial U.S. public offering and $266 million public follow-on offering
  • BeiGene, Ltd. in its $182 million initial public offering and $200 million, $201 million and $800 million follow-on public offerings
  • ConforMIS, Inc. in its $23 million follow-on offering
  • Galapagos NV in its $275 million initial U.S. public offering and $371 million follow-on offering 
  • Intellia Therapeutics, Inc. in its $150 million follow-on offering

Mergers and Acquisitions

  • Charlesbank Capital Partners, LLC, regarding intellectual property matters, in its respective investments in, or purchases of, a variety of technology and other companies
  • Continuum Managed Services, LLC, regarding intellectual property matters, on its sale to an entity controlled by Thoma Bravo, LLC from Summit Partners
  • EPR Properties, regarding intellectual property matters, in its acquisition of CNL Lifestyle Properties together with a co-buyer, Och-Ziff Real Estate
  • Semma Therapeutics, Inc. in its acquisition of CytoSolv, Inc., a developer of encapsulating cell technology

Private Financings

  • Naurex, Inc. in its $80 million Series C financing
  • RaNA Therapeutics, LLC in its $55 million Series B financing
  • Semma Therapeutics, Inc. in its $44 million Series A financing and $114 million Series B financing

Prior to joining Goodwin, Mr. Lovendale served as a legal intern at The Law Office of Zick Rubin (now Rubin & Ulrich LLC)—a firm specializing in publishing law, copyright, trademark and intellectual property issues in higher education—and Community Action Program Legal Services, Inc. (CAPLAW).



In The News









J.D., 2014
Boston College Law School

(cum laude)

B.S., 2011
Utah State University

(cum laude)



Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique